On this page
- TL;DR
- Urinary incontinence VA rating: pad changes and appliances
- Urinary frequency, overactive bladder and catheter use
- Bladder diagnostic codes (DC 7512 to 7545)
- Bladder cancer presumptions: herbicide, Camp Lejeune and § 3.320a
- Bladder dysfunction secondary to a lumbar spine condition
- Why VA denies bladder claims
- Questions veterans ask about bladder conditions
- Bottom Line
Bladder claims at the Board cover a wide range of conditions. The umbrella includes bladder cancer, neurogenic bladder, interstitial cystitis, post-surgical bladder dysfunction, urinary incontinence from any cause, and bladder injury residuals. Claim Raven read 4,942 decided Board rulings on bladder conditions from 2021 to 2026. A ruling is one issue the Board decided in one decision; one decision often rules on several issues. Remand was the most common result, at 46.8 percent, and the grant rate of 23.3 percent sits close to the Board-wide 24.7 percent.
Many bladder claims are secondary claims, where a back or neurological condition caused or worsened the bladder problem, and many rely on a presumption; the Board section below shows how direct, secondary and presumptive claims fared. Most bladder codes say to rate as voiding dysfunction under 38 CFR § 4.115a, the same criteria that govern prostate residuals, using urine leakage, urinary frequency or obstructed voiding, and some allow urinary tract infection instead, whichever is predominant.
TL;DR
- Across 4,942 decided Board rulings on bladder conditions from 2021 to 2026, 23.3% were granted, 29.9% denied and 46.8% remanded. Remand is the most common outcome, and the grant rate is 1.4 points below the Board-wide 24.7%.
- Bladder codes include DC 7512 (chronic cystitis, including interstitial cystitis), DC 7515 (bladder stones), DC 7516 (bladder fistula), DC 7517 (bladder injury), DC 7518 (urethral stricture), DC 7519 (urethral fistula), DC 7528 (malignant neoplasms, shared with prostate cancer), DC 7542 (neurogenic bladder) and DC 7545 (bladder diverticulum).
- Leakage that needs pads rates 20, 40 or 60 percent by the number of daily changes. Frequency rates 10 to 40 percent. Catheterization for retention is listed at 30 percent, not automatically 60.
- Exact bladder-cancer lanes include 38 USC § 1116 for herbicide-covered service, 38 CFR §§ 3.307(a)(7) and 3.309(f) for Camp Lejeune, and 38 CFR § 3.320a for qualifying Gulf War and post-9/11 service.
- Bladder dysfunction from a lumbar spine condition is rated separately from the spine, and the Board section below lists bladder claimed secondary to a lumbar spine condition among its secondary pairs.
- The medical opinion the Board relied on tracked the result closely, and rating appeals were granted more often than service connection questions; the Board section below shows both.
Urinary incontinence VA rating: pad changes and appliances
The urine-leakage criteria in § 4.115a cover continual leakage, post-surgical urinary diversion, urinary incontinence, and stress incontinence. They rate on how often absorbent materials must be changed.
- 60%: Requiring the use of an appliance or the wearing of absorbent materials which must be changed more than 4 times per day
- 40%: Requiring the wearing of absorbent materials which must be changed 2 to 4 times per day
- 20%: Requiring the wearing of absorbent materials which must be changed less than 2 times per day
Record the medically necessary changes, not just how many pads you buy. Your underlying diagnosis determines whether VA uses this pathway, and frequency and obstructed voiding are alternative criteria, not extra percentages for the same dysfunction. Keep treatment notes, appliance prescriptions where relevant, and a dated account of leakage and required changes. For post-cancer residuals, also see bladder cancer and prostate cancer.
Source: 38 CFR § 4.115a, voiding dysfunction (opens in a new tab).
Urinary frequency, overactive bladder and catheter use
When frequency is the main problem, § 4.115a rates on the daytime voiding interval and nighttime voids.
- 40%: Daytime voiding interval less than one hour, or awakening to void five or more times per night
- 20%: Daytime voiding interval between one and two hours, or awakening to void three to four times per night
- 10%: Daytime voiding interval between two and three hours, or awakening to void two times per night
Overactive bladder means urgency, usually with daytime frequency and nighttime urination (PMID 29732215). It has no code of its own. Board decisions rate it under codes such as DC 7517 (Citation Nr. A25050820) or DC 7515 (Citation Nr. A25055053), both rated as voiding dysfunction, so the frequency or leakage criteria decide the percentage.
Obstructed voiding covers a weak stream and urinary retention. Retention requiring intermittent or continuous catheterization is listed at 30 percent, and marked obstructive symptoms with findings such as post-void residuals over 150 cc rate 10 percent. A catheter is not automatically 60 percent, but in a January 2025 decision the Board treated a veteran's catheter as the "appliance" in the leakage criteria and assigned 60 percent (Citation Nr. 25000486).
Recurrent urinary tract infection rates 10 percent with one or two hospitalizations a year or suppressive drug therapy for six months or longer, and 30 percent with drainage by stent or nephrostomy tube, more than two hospitalizations a year, or continuous intensive management. Where a code points to these areas, § 4.115a says "only the predominant area of dysfunction shall be considered for rating purposes."
Bladder diagnostic codes (DC 7512 to 7545)
These are the bladder codes that matter most for Board-level claims.
DC 7517: Injury of the bladder
Rated as voiding dysfunction. This covers bladder injury residuals, such as trauma during service or surgical complications.
DC 7518: Stricture of the urethra
A narrowing of the urethra. Rated as voiding dysfunction.
DC 7516: Fistula of the bladder
Rated as voiding dysfunction or urinary tract infection, whichever is predominant, with 100 percent for a postoperative suprapubic cystotomy. A fistula of the urethra is DC 7519, rated as voiding dysfunction, with 100 percent for multiple urethroperineal fistulae.
DC 7512: Chronic cystitis, including interstitial cystitis
DC 7512 covers chronic cystitis of all causes, infectious and non-infectious, including interstitial cystitis, rated as voiding dysfunction. There is no separate diagnostic code for partial removal of the bladder; DC 7520 is removal of half or more of the penis.
DC 7528: Malignant neoplasms of the genitourinary system
This is the bladder cancer code, shared with prostate cancer. The 100 percent rating continues after treatment ends, with a mandatory VA exam at six months. Without local recurrence or metastasis, the rating then moves to residuals, as voiding dysfunction or renal dysfunction, whichever is predominant.
DC 7542: Neurogenic bladder
Rated as voiding dysfunction or urinary tract infection, whichever is predominant. Neurogenic bladder is bladder dysfunction from damage to the nerves that control it, seen with conditions such as spinal cord injury, multiple sclerosis, spina bifida, Parkinson's disease and stroke (PMID 38725892). The rating covers the urinary symptoms, not the underlying neurological condition.
Other bladder and related codes
DC 7515, bladder stones, is rated as voiding dysfunction. DC 7545, bladder diverticulum, is rated as voiding dysfunction or urinary tract infection, whichever is predominant. DC 7522, erectile dysfunction, is rated 0 percent with review for special monthly compensation under 38 CFR § 3.350; the 2021 genitourinary rule (86 FR 54081) removed the former compensable rating for penile deformity.
Bladder cancer presumptions: herbicide, Camp Lejeune and § 3.320a
Bladder cancer has three presumptive paths, each with its own service rule. The bladder cancer page covers that claim in more depth.
The Camp Lejeune presumptive path
The VA disability presumption is in 38 CFR §§ 3.307(a)(7) and 3.309(f). It covers veterans, former reservists, and former National Guard members who served at Camp Lejeune or Marine Corps Air Station New River between August 1, 1953, and December 31, 1987, for at least 30 cumulative days, subject to the regulation's requirements. The Camp Lejeune Justice Act of 2022 created a separate federal cause of action and is not the source of this VA disability presumption.
The covered conditions explicitly include bladder cancer. They don't cover non-cancer bladder conditions like interstitial cystitis or neurogenic bladder, but a non-cancer bladder condition medically connected to a presumptive condition can support a secondary claim. The Board data does not split presumptions by framework, so it cannot show a Camp Lejeune result on its own.
The herbicide lane and bladder cancer
The current herbicide statute, 38 USC § 1116(a)(2), lists bladder cancer as a presumptive disease for veterans with qualifying covered service. Congress added it through the FY2021 NDAA (Pub. L. 116-283, § 9109, signed January 1, 2021), not the PACT Act. The current § 3.309(e) table has lagged some later statutory additions, so § 1116 is the controlling citation for bladder cancer rather than a claim that the regulatory table itself lists it. The presumption covers bladder cancer, not BPH, interstitial cystitis or other non-cancer conditions, but bladder dysfunction left after cancer treatment is rated as a residual of the service-connected cancer.
The 2025 toxic-exposure presumption under 38 CFR § 3.320a
VA added 38 CFR § 3.320a through an interim final rule effective January 2, 2025. The rule presumes service connection for urinary bladder cancer, including overlapping sites of the bladder, for a covered veteran. It also covers ureter cancer, including the ureteric orifice and urachus.
The regulation defines its own covered-service groups: service in the Southwest Asia theater of operations or Somalia, including airspace above both, during the Persian Gulf War on or after August 2, 1990; and service in Afghanistan, Djibouti, Egypt, Jordan, Lebanon, Syria, Yemen, or Uzbekistan, including airspace, on or after September 11, 2001.
Section 1119 can establish presumed toxic exposure for covered PACT Act service, but it is not the bladder-cancer disease presumption. For this path, cite § 3.320a. The original 2022 list in § 1120 did not itself name bladder cancer; VA added this presumption in 2025 using its additional-presumption authority.
Bladder dysfunction secondary to a lumbar spine condition
The Board section below lists bladder claimed secondary to a lumbar spine condition among its secondary pairs. The medical path is nerve compression: cauda equina syndrome, most often caused by a lumbar disc herniation, compresses the nerve roots in the lower spinal canal, and bladder dysfunction is one of its defining signs (PMID 38186331, PMID 34473966). See the back and herniated disc pages for the spine side of the claim.
Note (1) to the spine rating formula in 38 CFR § 4.71a says to "evaluate any associated objective neurologic abnormalities, including, but not limited to, bowel or bladder impairment, separately." A bladder problem caused by your back is therefore rated on its own, under a bladder code such as DC 7542, in addition to the spine rating.
In a June 2025 decision, a private DBQ diagnosed neurogenic bladder and urinary frequency and explained how the veteran's low back condition led to nerve damage; with no convincing opinion against it, the Board granted the bladder claim (Citation Nr. A25053752). Other 2025 grants for voiding dysfunction secondary to a lumbar or low back condition include Citation Nr. A25022113 and A25047167. The opinion has to cover both parts of 38 CFR § 3.310: that the back condition caused the bladder problem, or that it aggravated it, meaning the bladder problem would be less severe but for the back condition. An opinion that skips aggravation is inadequate (El-Amin v. Shinseki, 26 Vet. App. 136 (2013)).
Why VA denies bladder claims
When the Board denied bladder service connection, the part it most often found missing was a link to service, followed by a current diagnosis. When it remanded, the most common reason was an inadequate VA exam or opinion. The Board section below shows how often each part failed, why claims were sent back, and what happened to legacy appeals after a remand.
No opinion that explains the path. A secondary claim needs an opinion that names the mechanism, such as nerve compression from the spine or a neurological disease, ties it to your records, and addresses aggravation.
No confirmed diagnosis. DC 7528 rates a malignant neoplasm, so a bladder-cancer claim needs the biopsy or surgical pathology that confirms it; imaging or urine tests that only raise suspicion are not a diagnosis.
Qualifying service not documented. Each presumptive lane has its own service rule: herbicide-covered service for § 1116, at least 30 days at Camp Lejeune or MCAS New River, or the listed locations and dates for § 3.320a.
Pad changes, voiding intervals and catheter use not recorded. The rating needs the daily count of absorbent-material changes, the voiding interval and nighttime voids, or the catheterization order, in the urologist's records or the C&P report.
Residuals not documented at the six-month exam. After cancer treatment, the rating at the mandatory exam depends on what the residuals documentation shows.
Questions veterans ask about bladder conditions
What is the VA rating for urinary incontinence?
Urinary incontinence rates 20, 40 or 60 percent under 38 CFR § 4.115a: 20 percent when absorbent materials must be changed less than twice a day, 40 percent for 2 to 4 changes, and 60 percent for more than 4 changes or the use of an appliance.
What is the VA rating for overactive bladder?
Overactive bladder has no code of its own, so VA rates it as voiding dysfunction under a related code. Frequency rates 10, 20 or 40 percent, and leakage that needs pads rates 20 to 60 percent, whichever is predominant.
What is the VA rating for neurogenic bladder?
Neurogenic bladder is DC 7542, rated as voiding dysfunction or urinary tract infection, whichever is predominant. That allows up to 60 percent for leakage needing more than four pad changes a day or an appliance.
Does a catheter get a 60 percent bladder rating?
Not automatically. Retention requiring catheterization is listed at 30 percent, but the Board has treated a catheter as the appliance in the 60 percent leakage criteria, so ask the rater to consider both.
Can bladder problems be secondary to a back condition?
Yes. The spine rating formula says bladder impairment from a spine condition is rated separately, and the Board has granted these claims when a medical opinion explained the nerve path.
Is bladder cancer a presumptive condition for veterans?
Yes, under three separate rules: 38 USC § 1116 for herbicide-covered service, 38 CFR §§ 3.307(a)(7) and 3.309(f) for Camp Lejeune, and 38 CFR § 3.320a for covered Gulf War and post-9/11 service.
Bottom Line
Bladder conditions are rated under DC 7512 through DC 7545 at 38 CFR § 4.115b, and most non-cancer conditions get their percentage from the voiding dysfunction or urinary tract infection criteria at § 4.115a. Countable facts decide the level: pad changes per day, voiding intervals, nighttime voids and catheter use. In Claim Raven's read of 4,942 decided Board rulings on bladder conditions, the grant rate is 23.3 percent and remand is the most common outcome. Exact bladder-cancer presumptions include 38 USC § 1116, 38 CFR §§ 3.307(a)(7) and 3.309(f), and 38 CFR § 3.320a; the § 3.320a presumption became effective January 2, 2025 and was not part of the original 2022 § 1120 disease list. Bladder dysfunction caused by a lumbar spine condition is rated separately from the spine.
Methodology and Limitations
- Data source: 38 CFR § 4.115b DC 7512 through DC 7545, 38 CFR § 4.115a (genitourinary dysfunction criteria), 38 CFR § 4.71a Note (1) to the spine formula, 38 CFR § 3.310, 38 USC § 1116 (herbicide presumption), 38 CFR §§ 3.307(a)(7) and 3.309(f) (Camp Lejeune), 38 CFR § 3.320a (urinary bladder and ureter cancer, including cancer of the ureteric orifice and urachus, effective January 2, 2025), and 38 USC §§ 1119 and 1120 (related PACT Act authorities and limits), checked in October 2026, and Claim Raven's read of every Board decision from 2021 to 2026 that it holds: 511,036 decisions containing 1,378,030 rulings.
- Sample size: 5,424 Board rulings on bladder conditions, 4,942 of them decided. Of the decided rulings, 1,150 were granted (23.3%), 1,477 denied (29.9%) and 2,315 remanded (46.8%). The Board section on this page breaks these down by denial reason, remand reason, results after a remand, appeal type, medical opinion, claim theory, diagnostic code, era and secondary pair; those figures are computed from the data, not typed here. The read does not code rating tiers.
- Limitations: The read captures Board-level decisions. Bladder claims granted at the regional office without appeal aren't in it. Bladder cancer also has its own page with its own Board figures, and the rating mechanics differ significantly between cancer and non-cancer conditions. Current statutory and regulatory text controls each presumptive path. Some Board decisions address neurogenic bladder under the underlying neurological condition rather than as a bladder issue; this read counts rulings on the bladder itself. These figures are associations, not causes. These observations describe BVA patterns and are not predictions of individual outcomes, and Claim Raven is data analysis, not legal, medical, or VA-accredited advice.